NASDAQ:ALMR Alamar Biosciences Q1 2026 Earnings Results & Report $28.00 +2.63 (+10.37%) As of 02:22 PM Eastern Alamar Biosciences reported Q1 2026 earnings on May 8, 2026. The company reported EPS of -$1.74, while revenue was $26.04 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2026Report DateMay 8, 2026TimeBefore Market OpensConference Call9:30 AM ET Alamar Biosciences EPS ResultsActual EPS-$1.74Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAlamar Biosciences Revenue ResultsActual Revenue$26.04 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Alamar Biosciences Q1 2026 Earnings FAQ Did Alamar Biosciences beat earnings estimates for Q1 2026? Alamar Biosciences (NASDAQ:ALMR) reported earnings of -$1.74 per share for Q1 2026. The report was announced on Friday, May 8, 2026. What was Alamar Biosciences' revenue for Q1 2026? Alamar Biosciences reported revenue of $26.04 million for Q1 2026. Alamar Biosciences Earnings HeadlinesAlamar Biosciences Inc (ALMR)October 13 at 7:40 PM | investing.comAlamar Biosciences, Inc. (NASDAQ:ALMR) Stock Has Consensus Price Target of $31.80 According to AnalystsOctober 9, 2026 | americanbankingnews.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.October 15 at 1:00 AM | Chaikin Analytics (Ad)Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026October 8, 2026 | finance.yahoo.comAlamar: The Consumables Flywheel Is Just Getting StartedOctober 8, 2026 | seekingalpha.comAlamar Biosciences, Inc.'s (NASDAQ:ALMR) Lock-Up Period To End on October 14thOctober 7, 2026 | americanbankingnews.comSee More Alamar Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Alamar Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alamar Biosciences and other key companies, straight to your email. Email Address About Alamar BiosciencesAlamar Biosciences (NASDAQ:ALMR) is a life sciences tools company focused on advancing proteomics, the study of proteins and their role in health and disease. The company develops technologies designed to enable highly sensitive, multiplexed analysis of proteins from small biological samples, supporting research in areas such as oncology, neurology, immunology and drug development. Its primary offering is the NULISA platform, which uses proprietary digital immunoassay and molecular barcoding technologies to measure multiple protein biomarkers simultaneously. The company has introduced NULISAseq and related assay panels for applications including inflammation, neurological disease and broader plasma protein profiling. Alamar also offers instrumentation and workflow solutions, including the ARGO HT automated platform, to support high-throughput proteomics research. Founded in 2018 and based in Fremont, California, Alamar Biosciences serves academic and government researchers, pharmaceutical and biotechnology companies, and clinical research organizations. Its products are intended to help customers identify biomarkers, characterize disease biology and evaluate potential therapies.View Alamar Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling?UnitedHealth Beats on Earnings, But Investors Question Growth Path Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
